Insider Transactions in Q4 2024 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 19
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
197
-0.12%
|
$394
$2.17 P/Share
|
Oct 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.07%
|
$214
$2.12 P/Share
|